ConductScience.org, home

Trial · NCT07895979

Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySubjective Cognitive Decline Questionnaire (SCD-Q)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
Assessed via a semi-structured interview based on the 24 items of the Subjective Cognitive Decline Questionnaire (SCD-Q). Participants identify up to 5 of their most concerning daily life cognitive difficulties and rate each item on two dimensions: (1) Frequency of occurrence, rated from 1 to 10 (where 10 indicates very frequent occurrence), and (2) Perceived distress/bother level, rated from 1 to 10 (where higher scores indicate lower distress, with 10 representing no distress at all).
PrimaryThe Brief University of California San Diego Performance-Based Skills Assessment-Traditional Chinese Version (UPSA-B)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
An objective, performance-based measure that evaluates instrumental activities of daily living (IADL) in simulated real-world scenarios across two domains: financial skills and communication skills (telephone use). Total scores range from 0 to 100, with higher scores indicating better everyday functional performance.
PrimaryIADL Context-Based Cognitive Flexibility Assessment (ICFA)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
A performance-based assessment evaluating cognitive flexibility within daily life contexts across 5 IADL-related scenarios (e.g., public transportation use, financial management, and daily life problem-solving). Each scenario consists of two parts assessing (1) spontaneous cognitive flexibility and (2) reactive cognitive flexibility (including intra-dimensional and extra-dimensional shifting). Higher scores indicate better real-life cognitive flexibility.
Secondarythe Taiwanese Version of the Montreal Cognitive Assessment (MoCA-T)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
Assesses global cognitive function across 8 cognitive domains: visuospatial/executive function, naming, memory, attention, language, abstraction, delayed recall, and orientation. Total scores range from 0 to 30, with higher scores indicating better global cognitive function.
SecondaryColor Trails Test (CTT)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
Evaluates sustained attention, alternating attention, and executive function. Consists of two parts: CTT-1 requires connecting numbered circles from 1 to 25 in sequence as quickly as possible; CTT-2 requires connecting numbered circles from 1 to 25 while alternating between pink and yellow colors. Measured by completion time (in seconds), where shorter completion times indicate better attention and executive functioning.
Secondarythe Wechsler Memory Scale-Third Edition (WMS-III) Family Pictures SubtestBaseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
Evaluates immediate and delayed visual memory. Participants view 4 pictures of family scenes and are asked to recall the characters, their spatial locations, and their activities immediately and after a 25-to-35-minute delay. Scores for both immediate recall and delayed recall range from 0 to 64, with higher scores indicating better visual memory.
Secondarythe Wechsler Memory Scale-Third Edition (WMS-III) Spatial Span SubtestBaseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
Assesses visuospatial working memory. Participants tap blocks on a board in the same order (Spatial Span Forward) or reverse order (Spatial Span Backward) as demonstrated by the examiner. Scores for the forward and backward subscales each range from 0 to 16 (total score range: 0 to 32), with higher scores indicating better visuospatial working memory.
SecondaryFunctional Magnetic Resonance Imaging (fMRI)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
Evaluates changes in resting-state functional connectivity using a 3.0-Tesla MRI scanner (Magnetom Prisma, Siemens). Includes T1-weighted structural MRI (MPRAGE sequence) and blood-oxygen-level-dependent (BOLD) resting-state functional EPI sequences to assess neural network changes before and after the cognitive intervention.
SecondaryWord Sequence Learning TestBaseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
Assesses short-term and delayed verbal memory across learning and 10-minute delayed recall phases. Scoring includes position score (range: 0 to 60), accuracy score (range: 0 to 60), total learning score (range: 0 to 20), and 10-minute delayed recall score (range: 0 to 30). Higher scores in each component indicate better verbal learning and memory performance.
SecondaryTower of Hanoi (TOH) Completion TimeBaseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
A performance-based task evaluating executive planning and problem-solving skills. Participants move perforated disks of varying sizes across three pegs from an initial state to a goal state while adhering to specific rules. This outcome assesses task execution efficiency, measured as the total completion time in seconds across all test trials. Shorter completion times indicate better planning and problem-solving ability.
SecondaryTower of Hanoi (TOH) Total MovesBaseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
A performance-based task evaluating executive planning and problem-solving skills. Participants move perforated disks of varying sizes across three pegs from an initial state to a goal state while adhering to specific rules. This outcome assesses movement efficiency, measured as the total number of moves made to complete the task. Fewer moves indicate more efficient planning and problem-solving ability.
SecondaryTower of Hanoi (TOH) Rule ViolationsBaseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
A performance-based task evaluating executive planning and problem-solving skills. Participants move perforated disks of varying sizes across three pegs from an initial state to a goal state while adhering to specific rules (e.g., only one disk may be moved at a time, and a larger disk may never be placed on top of a smaller disk). This outcome assesses rule-following and inhibitory control during problem-solving, measured as the total number of rule violations committed across the test trials. Fewer rule violations indicate better executive control and planning ability.
SecondaryGeriatric Depression Scale Short-Form (GDS-S)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
A 15-item self-report questionnaire assessing the severity of depressive symptoms in older adults. Total scores range from 0 to 15, with higher scores indicating more severe depressive symptoms (a score of 8 or higher suggests clinically significant depressive symptoms).
SecondaryBeck Anxiety Inventory (BAI)Baseline (within 2 weeks prior to intervention) and post-intervention (within 2 weeks after the 12-week intervention)
A 21-item self-report inventory measuring the severity of emotional and somatic symptoms of anxiety. Each item is rated from 0 to 3, yielding a total score ranging from 0 to 63. Higher scores indicate more severe anxiety (8-15: mild to moderate anxiety; 16-25: moderate to severe anxiety; 26-63: severe anxiety).

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07895979/registered